MX2021008858A - Vitamina b2 para la diabetes gestacional. - Google Patents

Vitamina b2 para la diabetes gestacional.

Info

Publication number
MX2021008858A
MX2021008858A MX2021008858A MX2021008858A MX2021008858A MX 2021008858 A MX2021008858 A MX 2021008858A MX 2021008858 A MX2021008858 A MX 2021008858A MX 2021008858 A MX2021008858 A MX 2021008858A MX 2021008858 A MX2021008858 A MX 2021008858A
Authority
MX
Mexico
Prior art keywords
vitamin
pregnant
woman
gestational diabetes
relates
Prior art date
Application number
MX2021008858A
Other languages
English (en)
Inventor
Keith Malcom Godfrey
Philip Newton Baker
Yap Seng Chong
Zolezzi Irma Silva
Catherine Mace
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2021008858A publication Critical patent/MX2021008858A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/64—Sugar alcohols
    • A23V2250/641—Inositol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/704—Vitamin B
    • A23V2250/7044—Vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición de nutrición materna que comprende mioinositol y vitamina B2. Una composición tal se ha diseñado específicamente para proporcionar una nutrición óptima para una mujer que desee la gestación, una mujer gestante y/o para una mujer en período de lactancia. La presente invención se refiere, además, a la vitamina B2 para usar para tratar o prevenir la diabetes mellitus gestacional y una afección asociada con esta en un sujeto gestante o su descendencia, en donde la vitamina B2 se administra a dicho sujeto antes y/o durante la gestación y/o durante la lactancia.
MX2021008858A 2014-08-08 2017-02-07 Vitamina b2 para la diabetes gestacional. MX2021008858A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14180403 2014-08-08
EP14180396 2014-08-08
EP14180401 2014-08-08
EP15170915 2015-06-05
EP15170911 2015-06-05

Publications (1)

Publication Number Publication Date
MX2021008858A true MX2021008858A (es) 2021-08-11

Family

ID=53836570

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017001738A MX2017001738A (es) 2014-08-08 2015-08-06 Vitamina b2 para la diabetes gestacional.
MX2021008858A MX2021008858A (es) 2014-08-08 2017-02-07 Vitamina b2 para la diabetes gestacional.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017001738A MX2017001738A (es) 2014-08-08 2015-08-06 Vitamina b2 para la diabetes gestacional.

Country Status (8)

Country Link
EP (2) EP3177151B1 (es)
CN (1) CN106573004B (es)
BR (1) BR112017002176B1 (es)
CA (1) CA2953286C (es)
ES (1) ES2802985T3 (es)
MX (2) MX2017001738A (es)
PH (1) PH12017500085A1 (es)
WO (1) WO2016020489A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE1650462A1 (en) * 2016-04-05 2017-10-06 Indevex Ab (Publ) A macronutrient composition for use in a method for treatment of gestational diabetes
KR20180049731A (ko) 2016-11-03 2018-05-11 주식회사 쎌바이오텍 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
CN108872424A (zh) * 2018-04-16 2018-11-23 南京医科大学 十二烷酸和前列腺素e2组合作为巨大儿辅助诊断标志物及其应用
CN110101088A (zh) * 2019-05-09 2019-08-09 武汉正轩宇生物科技有限公司 用于妊娠糖尿病防治的精准营养代餐组合物及其使用方法
CA3150034A1 (en) * 2019-08-26 2021-03-04 Societe Des Produits Nestle S.A. Myo-inositol and the prevention of pprom
CN115460934A (zh) * 2019-08-26 2022-12-09 雀巢产品有限公司 肌醇和早产的预防
JP2022546267A (ja) * 2019-08-30 2022-11-04 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ｓｃｙｌｌｏ－イノシトール及びβ細胞介在性疾患
CN115484939A (zh) * 2019-09-24 2022-12-16 雀巢产品有限公司 鲨肌醇及其作为胰岛素敏化剂的用途
CA3178154A1 (en) * 2020-06-22 2021-12-30 Zolezzi Irma Silva Compositions comprising myo-inositol and their use in the prevention of post partum haemorrhage (pph)
CA3191387A1 (en) 2020-09-30 2022-04-07 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043571A1 (en) * 1999-12-14 2001-06-21 Scott Conrad Hohulin Dietary supplement system
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
EP1549151A1 (en) * 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
EP1932542A1 (en) * 2006-12-15 2008-06-18 TIMA Foundation Antioxidant composition and its use in diabetes
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
US20140161878A1 (en) * 2012-12-12 2014-06-12 Sweet Wellness AB Multi-nutrient supplement and uses thereof
US20170087161A1 (en) * 2014-03-21 2017-03-30 Nestec S.A. Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring

Also Published As

Publication number Publication date
CA2953286A1 (en) 2016-02-11
EP3177151B1 (en) 2020-04-22
MX2017001738A (es) 2017-08-10
EP3177151A1 (en) 2017-06-14
BR112017002176A2 (pt) 2017-11-21
CN106573004A (zh) 2017-04-19
ES2802985T3 (es) 2021-01-22
WO2016020489A1 (en) 2016-02-11
CN106573004B (zh) 2021-07-16
PH12017500085A1 (en) 2017-05-22
EP3718418A1 (en) 2020-10-07
BR112017002176B1 (pt) 2022-03-22
CA2953286C (en) 2023-05-02

Similar Documents

Publication Publication Date Title
MX2021008858A (es) Vitamina b2 para la diabetes gestacional.
PH12017500014A1 (en) Myo-inositol and one or more probiotic and use thereof
PH12017550030A1 (en) Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
AR097151A1 (es) Alimento para rumiantes lactantes
MX2016009278A (es) Composicion que comprende okra para utilizarse en reducir la absorcion de grasas dieteticas.
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
WO2016137164A3 (ko) 바실러스 속 세균 유래 세포밖 소포체를 포함하는 임신관련 질환 치료용 조성물
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
PH12020550463A1 (en) Human milk fortifier composition
MX2017004651A (es) Composiciones para incrementar la produccion de grasa lactea en rumiantes lactantes y metodos para utilizar las mismas.
PH12017500051A1 (en) Nutritional composition for use to treat or prevent pregnancy related conditions
MX2017001632A (es) Mioinositol y probioticos, y uso de estos.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
MX2017003217A (es) Tratamiento del cancer con el inhibidor de la alfa-amilasa en los animales de compañía.
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
MX2019015889A (es) Administracion de vitamina b6 materna para la prevencion del aumento de la adiposidad, el sobrepeso a la obesidad en la descendencia.
MX2018002531A (es) Metodos para aumentar la absorcion de vitaminas liposolubles en la alimentacion.
PH12015502160A1 (en) Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women
MX2022002064A (es) Mioinositol y la prevencion del parto prematuro.
MX2022002063A (es) Mioinositol y la prevencion de pprom.
MX2021010210A (es) Una composicion nutricional para usar para mejorar la funcion ejecutiva.
PH12016500915A1 (en) Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers
UA75384U (ru) Способ профилактики осложнений в послеродовом периоде у женщин с фиброзно-кистозной болезнью молочных желез
MX2016011801A (es) Crema de estradiol de dosis baja.
UA106165U (uk) Спосіб лікування фіброзно-кістозної мастопатії у жінок з міомою матки